Stroke is a major health concern and an intensive research subject due that it is the major cause of death and the leading cause of disability worldwide. The past three decades of clinical disappointments in treating stroke must compel us to rethink our strategy. New effective protocol for stroke could greatly benefit from the advances in optical imaging technologies. This review focuses on the latest advance of applications of three optical imaging techniques in animal model of stroke, such as photoacoustic (PA) imaging, laser speckle contrast imaging (LSCI) and two-photon microscopy (TPM). The potential roles of those techniques in the future of stroke management are also discussed.
Stroke, or cerebrovascular accident, is the rapid loss of brain function due to disturbance in the blood supply to the brain. This can be due to ischemia caused by blockage, or hemorrhage [ 1]. Stroke is the major cause of death and the leading cause of disability worldwide. It is projected that between the years of 2005–2050 the care of stroke patients will cost an estimated 1.52 trillion dollars [ 2]. Therefore, stroke is a major health concern and an intensive research subject.
Considerable advances have been made in understanding the pathology of ischemic stroke. Although interrupting key pathogenic mechanisms has significantly improved outcome in animal stroke models, translating those into effective clinical treatments has been challenging [ 3]. The past three decades of clinical disappointments in treating stroke must compel us to rethink our strategy [ 3].
Current high resolution brain imaging methods in clinic include X-ray computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. However, CT uses ionizing radiation and MRI uses a strong magnetic field, and both methods are costly. Ultrasonography can only be used in pediatric brain imaging, and then only before closure of the fontanel. In addition, functional brain images are provided by functional MRI (fMRI), electroencephalography (EEG), magnetoencephalography (MEG), positron emission tomography (PET), single photon emission computed tomography (SPECT). Only fMRI, PET and SPECT can provide high resolution. But fMRI is expensive and has a low temporal resolution, and PET and SPECT use radioactive contrast agents [ 4].
Compared to MRI, optical technology promises to be quicker, cheaper, simpler, and more versatile [ 3]. New effective protocol for stroke could greatly benefit from the advances in optical technologies.
The use of novel optical imaging technologies has been instrumental for a number of central discoveries in both basic and clinical neuroscience, and Fig. 1 shows an overview of optical imaging technologies with different resolutions and penetration depth [ 5]. Optical imaging tools have played an important role in the study of neurovascular and neurometabolic disregulation in animal models of stroke [ 6]. Likewise, noninvasive optical technologies have started making inroads into bedside imaging of blood flow and oxygen consumption in human stroke patients [ 7, 8].
This review mainly focuses on the latest advance of applications of three optical imaging techniques in animal model of stroke, such as photoacoustic (PA) imaging, laser speckle contrast imaging (LSCI) and two-photon microscopy (TPM). The potential roles of those optical imaging techniques in the future of stroke management are also discussed.
Before we start our review of the studies, we will provide a brief overview of the parameters accessible to optical imaging measurements in stroke [ 9].
Changes in the concentrations of oxygenated hemoglobin (HbO), deoxygenated hemoglobin (HbR) and their sum, total hemoglobin (HbT), where HbT= HbO+ HbR, have been able to be determined in stroke. But absolute quantification of HbO and HbR is not yet reliable enough to allow the definition of thresholds for ischemia [ 9].
There have been several attempts to define a parameter that avoids the issue of absolute quantification of HbR and HbO, but still supplies a value that can be used as a threshold to monitor the brain potentially in acute stroke care [ 9]. Such values usually target cerebral blood or tissue oxygenation (rSO2: regional oxygen saturation; TOI: tissue oxygenation index). The terms blood and tissue oxygenation are used interchangeably in the literature [ 9].
Since stroke is caused by a reduction of cerebral blood flow (CBF), the ability of optical imaging to monitor cerebral perfusion has been a focus of research on the changes of blood flow.
The rapid loss of brain function results from changes of neuronal structure following stroke induced by disturbance in the blood supply to the brain. Changes of neuronal fine structure can be traced by optical imaging tools.
Since being discovered by Alexander Bell, photoacoustics may be seeing major resurgence in biomedical imaging [ 10]. It has been broadly studied in biomedicine, for both human and small animal tissues [ 4]. The fundamental principle of the PA effect can be simply described: An object absorbs electromagnetic radiation energy, the absorbed energy converts into heat, and the temperature of the object increases. As soon as the temperature increases, thermal expansion takes place, generating acoustic pressure in the medium. However, steady thermal expansion (time invariant heating) does not generate acoustic waves; thus, the heating source is required to be time-variant [ 4]. Although most high-resolution pure optical detection methods are capable of detecting optical absorption, they are generally much less sensitive to optical absorption than PA detection [ 11].
A primary PA application in biomedicine is photoacoustic tomography (PAT). It is the cross-sectional or three-dimensional (3D) imaging of a material using the photoacoustic effect [ 12]. Commercially available high-resolution 3D optical imaging modalities—including confocal microscopy, TPM, and optical coherence tomography—have fundamentally impacted biomedicine. Unfortunately, such tools cannot penetrate biologic tissue deeper than the optical transport mean free path ~1 mm in the skin. PAT, which combines strong optical contrast and high ultrasonic resolution in a single modality, has broken through this fundamental depth limitation and achieved superdepth high-resolution optical imaging [ 13].
Currently, PAT has three major implementations: focused-scanning photoacoustic microscopy (PAM), photoacoustic computed tomography (PACT), and photoacoustic endoscopy (PAE). Whereas, PAM and PAE usually aim to image millimeters deep at micrometerscale resolution, PACT can be implemented for both microscopic and macroscopic imaging [ 4].
Optical-resolution PAM (OR-PAM) has been validated as a valuable tool for label-free volumetric microvascular imaging. As we known, a major obstacle in understanding the mechanism of ischemic stroke is the lack of a tool to noninvasively or minimally invasively monitor cerebral hemodynamics longitudinally. Hu et al. in 2011 applied OR-PAM to longitudinally study ischemic stroke induced brain injury in a mouse model with transient middle cerebral artery occlusion (tMCAO) [ 14]. OR-PAM showed that, during MCAO, the average hemoglobin SO2 values of feeder arteries and draining veins within the stroke core region dropped ~10% and ~34%, respectively. After reperfusion, arterial SO2 recovered back to the baseline; however, the venous SO2 increased above the baseline value by ~7%. Thereafter, venous sO2 values were close to the arterial SO2 values, suggesting eventual brain tissue infarction [ 14].
Besides, studying cerebral metabolism during ischemia has been limited by imaging modalities that have either good tissue penetration but low spatial resolution, or high resolution requiring invasive preparations (open-skull windows). In 2012, OR-PAM was also employed to longitudinally monitor cerebral metabolism through the intact skull of Swiss Webster mice before, during, and up to 72 h after a 1-h tMCAO (see Fig. 2) [ 15].
Recently, PAM combined with LSCI has been used to examine the changes in CBF, cerebral blood volume (CBV), and SO2 during and after 3-h acute focal ischemic rats [ 16]. The study suggested that combining LSCI and PAM provides an attractive approach for stroke detection in small animal studies.
PAT has limitations, as does any imaging technology. First, optical attenuation limits the penetration to ~5 cm when a resolution of less than 1 mm is desired in tissue [ 17, 18, 19]. Microwaves or radio waves can be used for deeper excitation, although the contrast origins differ. Second, ultrasound sustains strong reflection from gas–liquid or gas–solid interfaces, owing to the strong mismatch of acoustic impedances. Therefore, ultrasound signals cannot penetrate through gas cavities or lung tissues efficiently. For the same reason, ultrasonic detection requires direct contact between the ultrasonic transducers and the biologic tissue. Usually, ultrasound coupling gel is applied to the tissue surface to remove intervening air cavities. The development of non-contact optical detection for acoustic displacement is a potential solution to this problem [ 20, 21, 22, 23]. Third, ultrasound suffers from significant attenuation and phase distortion in thick bones, such as the human skull. Fortunately, unlike pulse-echo ultrasound imaging, PAT involves only oneway ultrasound attenuation through the skull. Sufficiently strong photoacoustic signals have been observed through Rhesus monkey skulls [ 24, 25]. The remaining challenge is to compensate for the phase distortion introduced by the skull.
In summary, PAT perfectly complements other biomedical imaging modalities by providing unique optical absorption contrast with highly scalable spatial resolution, penetration depth, and imaging speed. In light of its capabilities and flexibilities, PAT is expected to play a more essential role in stroke studies and clinical practice [ 26].
When an object is illuminated with coherent laser light, a speckle pattern, or random interference pattern, is produced at the camera due to the fact that the laser light reaching each pixel has traveled slightly different path lengths and adds coherence, both constructively and destructively. In many imaging systems, speckle is a significant source of noise, and considerable effort has been spent in eliminating speckle. However, the dynamics of the speckle pattern contains information about the motion of the scattering particles in the sample. When some of the scattering particles are in motion (i.e., blood cells), the speckle pattern fluctuates in time. When the exposure time of the camera is longer than the time scale of the speckle intensity fluctuations (typically less than 1 ms for biologic tissues), the camera integrates the intensity variations resulting in blurring of the speckle pattern [ 27]. In areas of increased motion, there is more blurring of the speckles during the camera exposure resulting in a lower spatial contrast of the speckles in these areas [ 27].
LSCI has emerged over the past decade as a powerful, yet simple, method for imaging of blood flow dynamics in real time [ 27]. The rapid adoption of LSCI for physiologic studies is due to the relative ease and low cost of building an instrument as well as the ability to quantify blood flow changes with excellent spatial and temporal resolution [ 27]. Although measurements are limited to superficial tissues with no depth resolution, LSCI has been instrumental in pre-clinical studies of neurological disorders [ 27]. Recently a number of technical advances have been developed to improve technique, such as the quantitative accuracy, temporal resolution [ 27], and so on. Those advances were briefly reviewed as follows:
As we known, laser speckle contrast analysis (LASCA) is limited to being a qualitative method for the measurement of blood flow and tissue perfusion as it is sensitive to the measurement configuration. The signal intensity is one of the parameters that can affect the contrast values due to the quantization of the signals by the camera and analog-to-digital converter (ADC). In 2013, Song and Elson deduced the theoretical relationship between signal intensity and contrast values based on the probability density function (PDF) of the speckle pattern and simplify it to a rational function [ 28]. A simple method to correct this contrast error is also suggested [ 28]. The experimental results demonstrate that this relationship can effectively compensate the bias in contrast values induced by the quantized signal intensity and correct for bias induced by signal intensity variations across the field of view [ 28].
He et al. presented a lateral laser speckle contrast analysis method combined with line beam scanning illumination to improve the sampling depth of blood flow imaging [ 29]. Both the phantom and animal experimental results suggest that localized illumination and LSCA can significantly enhance the deep blood flow signal to improve the sampling depth of LSCI compared with the traditional full-field illumination LSCA method [ 29].
Laser speckle spatial contrast analysis (LSSCA) is superior to laser speckle temporal contrast analysis (LSTCA) in monitoring the fast change in blood flow due to its advantage of high temporal resolution. However, the application of LSSCA, which is based on spatial statistics, may be limited when there is nonuniform intensity distribution, such as fibertransmitting laser speckle imaging. In this study, Zhang et al. presented a normalized laser speckle spatial contrast analysis (nLSSCA) to correct the detrimental effects of nonuniform intensity distribution on the spatial statistics [ 30]. Through numerical simulation and phantom experiments, it was found that just ten frames of dynamic laser speckle images are sufficient for nLSSCA to achieve effective correction [ 30]. Furthermore, nLSSCA has higher temporal resolution than LSTCA to respond the change in velocity [ 30]. LSSCA, LSTCA and nLSSCA are all applied in the fiber-transmitting laser speckle imaging system to analyze the change of CBF during cortical spreading depression (CSD) in rat cortex respectively, and the results suggest that nLSSCA can examine the change of CBF more accurately. For these advantages, nLSSCA could be a potential tool for fiber transmitting/ endoscopic laser speckle imaging [ 30].
This system has a frame rate of 10 Hz and can rapidly monitor changes in blood flow in vivo, using the contrast values of the speckle images recorded with 1 ms exposure time [ 31]. In addition, the mean intensities can record the respiration period and can indicate changes in tissue oxygenation [ 31]. This system was tested during an occlusion to a human finger and is being applied in endoscopy [ 31].
LSCI and optical intrinsic signals imaging (OISI) have been used for years in the study of CBF and hemodynamic responses to neural activity. So far, most in vivo rodent experiments are based on the anesthesia model when the animals are in unconscious and restrained conditions. As we known, the anesthesia has influences on the neural activity have been documented. Lu et al. designed a miniature head-mounted dual-modal imager in freely moving animals that could monitor in real time the coupling of local oxygen consumption and blood perfusion of CBF by integrating different imaging modalities of OIS and LSCI [ 32]. The system facilitates the study the cortical hemodynamics and neural-hemodynamic coupling in real time in freely moving animals [ 32].
Animal models of stroke are widely used to investigate the basic pathophysiology of stroke and to evaluate new stroke therapies. A critical aspect of these studies is monitoring of blood flow dynamics in the brain [ 33]. Laser Doppler flowmetry has been used for many years in such studies and is widely considered to be the gold standard for quantifying blood flow changes in the brain in animal models of stroke [ 33]. Although MRI and PET have also been used in animal models of stroke, the spatial and temporal resolution of these techniques is usually not sufficient to enable detailed studies of blood flow dynamics [ 33]. First introduced in the 1980s, LSCI is a powerful tool for full-field imaging of blood flow [ 33]. It has been used extensively in animal models of stroke because of its ability to provide real time images of the spatial and temporal blood flow dynamics. Here, a brief review on the latest development of LSCI in animal model of stroke was given as below:
LSCI has become a widely used technique to image cerebral blood flow in vivo. However, the quantitative accuracy of blood flow changes measured through the thin skull has not been investigated thoroughly. Parthasarathy et al. have recently developed a new multi exposure speckle imaging (MESI) technique to image blood flow while accounting for the effect of scattering from static tissue elements [ 34]. The MESI technique was used to image the blood flow changes in a mouse cortex following photothrombotic occlusion of middle cerebral artery [ 34]. The MESI was found to accurately estimate flow changes due to ischemia in mice brains in vivo [ 34]. These estimates of these flow changes were found to be unaffected by scattering from thinned skull [ 34].
Imaging blood flow or oxygenation changes using optical techniques is useful for monitoring cortical activity in healthy subjects as well as in diseased states. However, in order to gain a better understanding of hemodynamics in conscious, freely moving animals, these techniques must be implemented in a small scale, portable design that is adaptable to a wearable format. Levy et al. have demonstrated a novel system which combines the two techniques of LSCI and intrinsic optical signal imaging simultaneously, using compact laser sources, to monitor induced cortical ischemia in a full field format with high temporal acquisition rates [ 35]. They further demonstrated the advantages of using combined measurements of speckle contrast and oxygenation to establish absolute flow velocities, as well as to statistically distinguish between veins and arteries [ 35]. Levy et al. accomplished this system using coherence reduction techniques applied to vertical cavity surface emitting lasers (VCSELs) operating at 680, 795 and 850 nm. This system uses minimal optical components and can easily be adapted into a portable format for continuous monitoring of cortical hemodynamics [ 35].
Qin et al. described a newly developed synchronized dual-wavelength LSCI system, which contains two cameras that are synchronously triggered to acquire data [ 36]. The system can acquire data at a high spatiotemporal resolution (up to 500 Hz for 1000 × 1000 pixels) [ 36]. A mouse model of stroke is used to demonstrate the capability for imaging the fast changes (within tens of milliseconds) in oxygenated and deoxygenated hemoglobin concentration, and the relative changes in blood flow in the mouse brain, through an intact cranium [ 36]. This novel imaging technology will enable the study of fast hemodynamics and metabolic changes in vascular diseases [ 36].
CBF is critical for the maintenance of cerebral function by guaranteed constant oxygen and glucose supply to brain. Collateral channels (CCs) are recruited to provide alternatives to CBF to ischemic regions once the primary vessel is occluded during ischemic stroke. However, the knowledge of the relationship between dynamic evolution of collateral flow and the distribution of regional blood flow remains limited. Laser speckle imaging was used by Wang et al. to assess dynamic changes of CCs and regional blood flow in a rat cortex with permanent MCAO [ 37]. It was found that CCs immediately provided blood flow to ischemic territories after MCAO. More importantly, there were three kinds of dynamic changes of CCs during acute stroke: persistent CC, impermanent CC, and transient CC, respectively, related to different distributions of regional blood flow [ 37].
LSCI is a powerful method for real-time visualization of blood flow [ 27]. It is simple instrumentation and low cost that make LSCI readily accessible for many applications ranging from basic physiology to clinical settings [ 27]. Traditionally, LSCI has been limited to measurements of relative blood flow changes within a single animal [ 27]. Recent advances such as MESI, however, should enable chronic imaging of blood flow as well as improve the quantitative accuracy of blood flow imaging [ 27, 34]. In addition, speckle imaging combined with other optical imaging modalities should enable simultaneous multi-parameter imaging of a range of physiologic parameters [ 27].
Denk et al. developed the TPM technique, which allows visualizing small structures within the functioning brain of a living organism [ 38]. By using a pulsed infrared laser that excites fluorophores by the combined power of two long-wavelength photons, it was possible to achieve optical sectioning based on physical principles alone without difficulty in aligning optics or light losses due to confocal pinholes [ 39]. The use of infrared light was not only necessary for the 2-photon effect, but it had the added advantage of good tissue depth penetration. Optical sectioning result of TPM since the probability of 2-photon excitation is relatively low and is restricted to a narrow focal plane where excitation power is the highest [ 39].
TPM provides a number of advantages that will aid the study of the mechanisms underlying neurovascular coupling in animal models of stroke [ 40].
The majority of current preclinical stroke models focus on large-scale ischemic strokes that manifest severe behavioral deficits [ 41]. However, small cortical infarcts are prominent in cases of human small vessel disease and dementia, and are clinically difficult to detect [ 42, 43]. Optical access to the vasculature offers the opportunity for laser-mediated formation of intravascular clots in single vessels, as a model to study the effects of small-scale stroke in rats and mice [ 44– 47].
On the cortical surface, single vessel thrombosis is achieved by irradiating the lumen of the target vessel with a focused green laser to activate the circulating photo- sensitizing dye, Rose Bengal [ 48, 49]. Below the cortical surface, thrombosis is achieved by focusing high-fluence, 100 to 300-fs pulses of near infrared light into the vessel lumen [ 47]. Nonlinear absorption ensures that the laser injury is limited only to the plane of focus. In this case, damage of the vessel wall induces clot formation in the lumen [ 47].
Rose Bengal irradiation was applied to occlude one of many penetrating arterioles visible on the pial surface through a dura-removed cranial window in rat (Fig. 4(a)) or a PoRTS window in a CX(3)CR1 transgenic mouse with green fluorescent protein (GFP)-labeled microglia (Fig. 4(b)).
By using Thy1-YFP mice, the fine dendritic structure of deep neuronal populations can be imaged over a period of hours to days following stroke [ 50– 52]. In the example of Fig. 5, blood vessels (red channel in Fig. 5(a)) as well as the dendritic arbors of layer 5 neurons (green channel in Fig. 5(a)) are imaged through a dura intact cranial window [ 53]. Injection of Rose Bengal and irradiation of the vasculature with a broadly focused green laser causes flow to cease in all pial vessels in a region roughly 1 mm2 in area (right panel in Figs. 5(a) and 5(b)). In this case, severe ischemia leads to rapid dendritic damage over a period of 30 min, as evidenced by blebbing of the dendritic shafts (Figs. 5(c) and 5(d) [ 54]).
The recent application of TPM to biologic specimens has allowed investigators to examine individual synapses within live animals [ 55]. In the case of stroke, TPM imaging has revealed marked swelling of dendrites and loss of spines within minutes of ischemic onset [ 55]. Surprisingly, restoration of blood flow during reperfusion was associated with a return of relatively normal structure [ 55]. Over longer time scales, TPM imaging revealed elevated rates of synaptogenesis within peri-infarct tissues recovering from stroke [ 55]. These results provide an example of how high-resolution in vivo microscopy can be used to provide insight into both the acute pathology and recovery from stroke damage [ 55]. It have been outlined how recent advances in TPM have enabled the study of micrometer-level structures such as synapses to be studied in situ (Fig. 6) [ 55] and to define the vulnerability of the synapse with respect to regional differences in blood flow during stroke and reperfusion (Fig. 6) [ 55].
Although tissue death occurs within minutes to hours of the onset of reduced blood flow, functional recovery from stroke-induced brain injury continues weeks and months after the initial insult [ 61]. It has been suggested that this functional recovery occurs via adaptive plasticity in surviving neurons, whereby viable brain tissue reorganizes in order to rebuild or replace damaged synaptic connections and strengthen surviving neuronal networks [ 61– 66]. Indeed, it has been demonstrated in both human stroke patients and animal models of stroke that surviving regions of the cortex can adopt the motor- or sensory-processing functions of regions lost to damage [ 56, 67– 70]. In vivo 2-photon calcium imaging was introduced to determine how the response properties of individual somatosensory cortex neurons are altered during remapping [ 60].
Most stroke survivors exhibit a partial recovery from their deficits. This presumably occurs because of remapping of lost capabilities to functionally related brain areas [ 71]. Functional brain imaging studies suggest that remapping in the contralateral uninjured cortex might represent a transient stage of compensatory plasticity [ 71]. Some postmortem studies have also shown that stroke can trigger dendritic plasticity in the contralateral hemisphere, but the data are controversial [ 71]. Longitudinal in vivo TPM was used in the contralateral homotopic cortex to record changes in dendritic spines of layer 5 pyramidal neurons in green fluorescent protein mice [ 71]. Johnston et al. could not detect de novo growth of dendrites or changes in the density or turnover of spines for up to four weeks after stroke [ 71]. These results suggest that the contralesional cortex may not contribute to functional recovery after stroke and that, at least in mice, the peri-infarct cortex plays the dominant role in postischemic plasticity [ 71].
In the context of blood flow, the TPM technique has enabled depth-resolved measurements of RBC velocities [ 72] and vascular diameters [ 73, 74] routinely at depths of up to 500 mm deep in the cortex and as deep as 1 mm when utilizing advanced laser systems [ 75]. In contrast with LSCI, which utilizes Doppler contrast from RBC motion, TPM velocity measurements typically utilize a fluorescent dye to image the blood plasma and track the RBC ‘shadows’ to estimate velocity in individual capillaries [ 5]. While LSCI can be generally performed through a thin skull, TPM typically requires a cranial window, although thin skull measurements are now being conducted at the expense of depth penetration [ 53]. Velocity and diameter measurements are performed on no more than a few vessel segments at a time. As a result, studies that require measurements throughout the vascular geometry to ascertain the collective behavior are not practical with TPM [ 5].
In vivo TPM and transgenic mouse models expressing cell type specific reporters have been used to examine ischemia-related insults, e.g., perturbations of neuronal process morphology and local blood flow in the MCAO [ 76]. Glia and pericytes can be visualized by selective fluorescent protein expression [ 76]. In these mice, the breakdown of the blood brain barrier and the immediate as well as long-term cellular responses can be monitored [ 76].
One major limitation of this method is the need of a fluorescent specimen. Greatly improved staining approaches, however, made it possible to label specific neurons and pathways with genetic tools [ 77]. We also anticipate that with advances in surgical techniques and further miniaturization of equipment [ 78, 79], such high-resolution measurements will be routinely performed in even awake animals to chart the effects of stroke and recovery. Recent data also suggest that these methods may be important for evaluating the transient effect of peri-infarct depolarization induced by stroke [ 80].
Clinicians’ need for real-time information on the structure and function of human systems, as well as effects of disease, such as stroke; optical imaging holds promise in meeting these needs. The great challenge before us is how to make those optical techniques be transferred from bench to bedside. Here are no hard and fast rules but rather a series of lessons from experience. We need to make great efforts to theoretical and technological improvements, so that we can identify when optical imaging will be ready for the patient and what needs to be done to make optical imaging more useful to the patient.
1 |
|
2 |
|
3 |
|
4 |
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
25 |
|
26 |
|
27 |
|
28 |
|
29 |
|
30 |
|
31 |
|
32 |
|
33 |
|
34 |
|
35 |
|
36 |
|
37 |
|
38 |
|
39 |
|
40 |
|
41 |
|
42 |
|
43 |
|
44 |
|
45 |
|
46 |
|
47 |
|
48 |
|
49 |
|
50 |
|
51 |
|
52 |
|
53 |
|
54 |
|
55 |
|
56 |
|
57 |
|
58 |
|
59 |
|
60 |
|
61 |
|
62 |
|
63 |
|
64 |
|
65 |
|
66 |
|
67 |
|
68 |
|
69 |
|
70 |
|
71 |
|
72 |
|
73 |
|
74 |
|
75 |
|
76 |
|
77 |
|
78 |
|
79 |
|
80 |
|